CASE Statement Condemning Pelosi Destructive Drug Pricing Scheme
September 19, 2019 (Arlington, Virginia) — Today, CASE Vice President Gerard Scimeca issued a statement, condemning Speaker of the...
September 19, 2019 (Arlington, Virginia) — Today, CASE Vice President Gerard Scimeca issued a statement, condemning Speaker of the...
September 12, 2019 Earlier this week, a draft of Speaker of the House Nancy Pelosi’s drug pricing plan was leaked...
August 16, 2019 Last month, The Centers for Medicare and Medicaid Services released a new proposal which will increase price...
Yesterday, the U.S. Department of Health and Human Services released a proposal, outlining two pathways to allow for the importation...
(Arlington, Virginia) — CASE launches new ad imploring the Senate to abandon a proposal that would place inflationary price caps...
July 19, 2019 We recently learned that the White House is asking Senate Democrats to include two proposals in...
July 11, 2019 Back in January of this year millions cheered President Trump’s plan to finally hold pharmacy benefit managers...
July 8, 2019 43 million seniors in the United States rely on Medicare Part D to provide them with the...
July 1 2019 Last week’s Democratic primary debates were full of meaningful, substantive and inspired policy solutions. Just kidding. Last...
Gerard Scimeca – Chairman, CASE June 24, 2019 There are two priorities regarding healthcare in America on which nearly everyone...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2025 · Case for Consumers